Literature DB >> 20153821

Roles for the type III TGF-beta receptor in human cancer.

Catherine E Gatza1, Sun Young Oh, Gerard C Blobe.   

Abstract

Transforming growth factor beta (TGF-beta) superfamily ligands have important roles in regulating cellular homeostasis, embryonic development, differentiation, proliferation, immune surveillance, angiogenesis, motility, and apoptosis in a cell type and context specific manner. TGF-beta superfamily signaling pathways also have diverse roles in human cancer, functioning to either suppress or promote cancer progression. The TGF-beta superfamily co-receptor, the type III TGF-beta receptor (TbetaRIII, also known as betaglycan) mediates TGF-beta superfamily ligand dependent as well as ligand independent signaling to both Smad and non-Smad signaling pathways. Loss of TbetaRIII expression during cancer progression and direct effects of TbetaRIII on regulating cell migration, invasion, proliferation, and angiogenesis support a role for TbetaRIII as a suppressor of cancer progression and/or as a metastasis suppressor. Defining the physiological function and mechanism of TbetaRIII action and alterations in TbetaRIII function during cancer progression should enable more effective targeting of TbetaRIII and TbetaRIII mediated functions for the diagnosis and treatment of human cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20153821      PMCID: PMC2875339          DOI: 10.1016/j.cellsig.2010.01.016

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  118 in total

1.  Different routes of bone morphogenic protein (BMP) receptor endocytosis influence BMP signaling.

Authors:  Anke Hartung; Keren Bitton-Worms; Maya Mouler Rechtman; Valeska Wenzel; Jan H Boergermann; Sylke Hassel; Yoav I Henis; Petra Knaus
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

2.  Identification of distinct inhibin and transforming growth factor beta-binding sites on betaglycan: functional separation of betaglycan co-receptor actions.

Authors:  Ezra Wiater; Craig A Harrison; Kathy A Lewis; Peter C Gray; Wylie W Vale
Journal:  J Biol Chem       Date:  2006-04-18       Impact factor: 5.157

Review 3.  Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

4.  Betaglycan induces TGF-beta signaling in a ligand-independent manner, through activation of the p38 pathway.

Authors:  Cristian Santander; Enrique Brandan
Journal:  Cell Signal       Date:  2006-01-18       Impact factor: 4.315

Review 5.  Transforming growth factor-beta pathway: role in pancreas development and pancreatic disease.

Authors:  Sushil G Rane; Ji-Hyeon Lee; Huei-Min Lin
Journal:  Cytokine Growth Factor Rev       Date:  2005-10-27       Impact factor: 7.638

6.  Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung.

Authors:  Mitch Raponi; Yi Zhang; Jack Yu; Guoan Chen; Grace Lee; Jeremy M G Taylor; James Macdonald; Dafydd Thomas; Christopher Moskaluk; Yixin Wang; David G Beer
Journal:  Cancer Res       Date:  2006-08-01       Impact factor: 12.701

Review 7.  TGF-beta and cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2005-11-10       Impact factor: 7.638

Review 8.  Alterations in components of the TGF-beta superfamily signaling pathways in human cancer.

Authors:  Laurence Levy; Caroline S Hill
Journal:  Cytokine Growth Factor Rev       Date:  2005-11-23       Impact factor: 7.638

9.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

10.  Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.

Authors:  G Anumanthan; S K Halder; H Osada; T Takahashi; P P Massion; D P Carbone; P K Datta
Journal:  Br J Cancer       Date:  2005-11-14       Impact factor: 7.640

View more
  87 in total

1.  Coated pit-mediated endocytosis of the type I transforming growth factor-β (TGF-β) receptor depends on a di-leucine family signal and is not required for signaling.

Authors:  Keren E Shapira; Avner Gross; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

2.  c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas.

Authors:  Stefano Sioletic; Jeffrey Czaplinski; Lan Hu; Jonathan A Fletcher; Christopher D M Fletcher; Andrew J Wagner; Massimo Loda; George D Demetri; Ewa T Sicinska; Eric L Snyder
Journal:  J Pathol       Date:  2014-08-01       Impact factor: 7.996

3.  Role of Platelet-Derived Tgfβ1 in the Progression of Ovarian Cancer.

Authors:  Qianghua Hu; Takeshi Hisamatsu; Monika Haemmerle; Min Soon Cho; Sunila Pradeep; Rajesha Rupaimoole; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Stephen T C Wong; Anil K Sood; Vahid Afshar-Kharghan
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

4.  Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers.

Authors:  Yong-Hun Lee; William P Schiemann
Journal:  Breast Cancer Manag       Date:  2014

5.  miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.

Authors:  Duo Li; Ke Liu; Zhiyong Li; Jian Wang; Xiaofeng Wang
Journal:  Cell Adh Migr       Date:  2017-11-13       Impact factor: 3.405

6.  Endocardial cell epithelial-mesenchymal transformation requires Type III TGFβ receptor interaction with GIPC.

Authors:  Todd A Townsend; Jamille Y Robinson; Tam How; Daniel M DeLaughter; Gerard C Blobe; Joey V Barnett
Journal:  Cell Signal       Date:  2011-09-14       Impact factor: 4.315

Review 7.  Role of TGF-β and the tumor microenvironment during mammary tumorigenesis.

Authors:  Molly A Taylor; Yong-Hun Lee; William P Schiemann
Journal:  Gene Expr       Date:  2011

8.  Control of organization and function of muscle and tendon by thrombospondin-4.

Authors:  Ella G Frolova; Judith Drazba; Irene Krukovets; Volodymyr Kostenko; Lauren Blech; Christy Harry; Amit Vasanji; Carla Drumm; Pavel Sul; Guido J Jenniskens; Edward F Plow; Olga Stenina-Adognravi
Journal:  Matrix Biol       Date:  2014-03-01       Impact factor: 11.583

9.  Type III TGF-β receptor promotes FGF2-mediated neuronal differentiation in neuroblastoma.

Authors:  Erik H Knelson; Angela L Gaviglio; Alok K Tewari; Michael B Armstrong; Karthikeyan Mythreye; Gerard C Blobe
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

10.  CCN6 knockdown disrupts acinar organization of breast cells in three-dimensional cultures through up-regulation of type III TGF-β receptor.

Authors:  Anupama Pal; Wei Huang; Kathy A Toy; Celina G Kleer
Journal:  Neoplasia       Date:  2012-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.